Business Wire (press release) Cerebrovascular Adverse Reactions, Including Stroke: In placebo-controlled trials with risperidone, aripiprazole, and olanzapine in elderly subjects with dementia, there was a higher incidence of cerebrovascular adverse reactions (cerebrovascular ... and more »
Business Wire (press release) Poster 79: “A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of ALKS 3831 in the Prevention of Olanzapine -Induced Weight Gain in Healthy Male Volunteers” will be presented by John M. Kane, M.D., Chairman of ... and more »
Irish Medical Times Risperidone, quetiapine, olanzapine and aripiprazole are commonly used for acute mania. Minor tranquillisers are commonly used with those medications and as the patient recovers, a decision is made whether to continue him or her on one antipsychotic.
7thSpace Interactive (press release) Conclusions: Results of this analysis support the efficacy and tolerability of olanzapine for the treatment of bipolar depression in Japanese patients. Results in this population were consistent with those seen in the more ethnically diverse parent study.
Wall Street Journal (press release) Poster 79: "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of ALKS 3831 in the Prevention of Olanzapine -Induced Weight Gain in Healthy Male Volunteers" will be presented by John M. Kane, M.D., Chairman of ... and more »
7thSpace Interactive (press release) Conclusions: Results of this analysis support the efficacy and tolerability of olanzapine for the treatment of bipolar depression in Japanese patients. Results in this population were consistent with those seen in the more ethnically diverse parent study.
Lexology (registration) The Federal Court has upheld the validity of Eli Lilly's Australian patent covering anti-psychotic drug olanzapine in a recent revocation action, with Apotex failing on all grounds. Olanzapine , marketed under the name ZYPREXA®, has enjoyed significant ...
Wall Street Journal (press release) (i) Eligible patients were then continued in a 12-month, double-blind, parallel-group study involving flexibly dosed LATUDA (40-160 mg/day) or quetiapine XR (200-800 mg/day). The primary efficacy endpoint of this study was time to first relapse of ...
Vancouver Sun Amitriptyline: 3.13 million, up 7.62%. Bupropion: 2.66 million, up 41.7%. Tranquillizers. Lorazepam: 7.39 million, up 12.7%. Quetiapine: 7.06 million, up 69%. Risperidone: 3.39 million, up 5.89%. Oxazepam: 2.6 million, up 5.22%. Olanzapine : 2.57 ...
Wall Street Journal (press release) Journal of Clinical Psychiatry. 2005; 66(9): 1122-1129. 4. Ascher-Svanum, Haya et al. A comparison of olanzapine and risperidone on the psychiatric hospitalization in naturalistic treatment of patients with schizophrenia. Annals of General Hospital ... and more »
